Goldman Sachs’s Eton Pharmaceutcials ETON Stock Holding History
Bought
Maintained
Sold
Other funds holding ETON
OM
Goldman Sachs's ETON Position: Q3 2026 in Review
Goldman Sachs increased its Eton Pharmaceutcials (ETON) stake by 98% in Q3 2026, buying an estimated $6.61M and bringing the position to 262,778 shares worth $13.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2932.
Goldman Sachs first reported a position in ETON in Q3 2021 and has held it in 13 quarters since. 213 funds tracked by Wall St. Rank hold ETON as of Q3 2026.
- Goldman Sachs held 262,778 shares of Eton Pharmaceutcials worth $13.5M as of Q3 2026.
- Goldman Sachs bought 130,195 Eton Pharmaceutcials shares in Q3 2026, an estimated $6.61M.
- Eton Pharmaceutcials made up ﹤0.01% of Goldman Sachs's portfolio in Q3 2026, its #2932 holding.
- Goldman Sachs first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 13 quarters since.
- 213 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q3 2026.
Based on Goldman Sachs's 13F filing for Q3 2026, filed 16 Nov 2026.